195 related articles for article (PubMed ID: 12649744)
1. A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer.
Iwashita Y; Tahara K; Goto S; Sasaki A; Kai S; Seike M; Chen CL; Kawano K; Kitano S
Cancer Immunol Immunother; 2003 Mar; 52(3):155-61. PubMed ID: 12649744
[TBL] [Abstract][Full Text] [Related]
2. TNF-α and tumor lysate promote the maturation of dendritic cells for immunotherapy for advanced malignant bone and soft tissue tumors.
Miwa S; Nishida H; Tanzawa Y; Takata M; Takeuchi A; Yamamoto N; Shirai T; Hayashi K; Kimura H; Igarashi K; Mizukoshi E; Nakamoto Y; Kaneko S; Tsuchiya H
PLoS One; 2012; 7(12):e52926. PubMed ID: 23300824
[TBL] [Abstract][Full Text] [Related]
3. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
Chang GC; Lan HC; Juang SH; Wu YC; Lee HC; Hung YM; Yang HY; Whang-Peng J; Liu KJ
Cancer; 2005 Feb; 103(4):763-71. PubMed ID: 15637694
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen.
Itoh T; Ueda Y; Kawashima I; Nukaya I; Fujiwara H; Fuji N; Yamashita T; Yoshimura T; Okugawa K; Iwasaki T; Ideno M; Takesako K; Mitsuhashi M; Orita K; Yamagishi H
Cancer Immunol Immunother; 2002 Apr; 51(2):99-106. PubMed ID: 11904734
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.
El Ansary M; Mogawer S; Elhamid SA; Alwakil S; Aboelkasem F; Sabaawy HE; Abdelhalim O
J Cancer Res Clin Oncol; 2013 Jan; 139(1):39-48. PubMed ID: 22886490
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma.
Chang JW; Hsieh JJ; Shen YC; Ho E; Chuang CK; Chen YR; Liao SK; Chen JS; Leong SP; Hou MM; Chang NJ; Wang CH
Melanoma Res; 2009 Oct; 19(5):309-15. PubMed ID: 19750589
[TBL] [Abstract][Full Text] [Related]
7. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
Curti A; Isidori A; Ferri E; Terragna C; Neyroz P; Cellini C; Ratta M; Baccarani M; Lemoli RM
Leuk Lymphoma; 2004 Jul; 45(7):1419-28. PubMed ID: 15359643
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
[TBL] [Abstract][Full Text] [Related]
9. Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.
Reichardt VL; Milazzo C; Brugger W; Einsele H; Kanz L; Brossart P
Haematologica; 2003 Oct; 88(10):1139-49. PubMed ID: 14555310
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.
Oosterwijk-Wakka JC; Tiemessen DM; Bleumer I; de Vries IJ; Jongmans W; Adema GJ; Debruyne FM; de Mulder PH; Oosterwijk E; Mulders PF
J Immunother; 2002; 25(6):500-8. PubMed ID: 12439347
[TBL] [Abstract][Full Text] [Related]
11. Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma.
Miwa S; Nishida H; Tanzawa Y; Takeuchi A; Hayashi K; Yamamoto N; Mizukoshi E; Nakamoto Y; Kaneko S; Tsuchiya H
Cancer; 2017 May; 123(9):1576-1584. PubMed ID: 28241093
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
Lee JJ; Kook H; Park MS; Nam JH; Choi BH; Song WH; Park KS; Lee IK; Chung IJ; Hwang TJ; Kim HJ
J Clin Apher; 2004; 19(2):66-70. PubMed ID: 15274198
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.
Kim JH; Lee Y; Bae YS; Kim WS; Kim K; Im HY; Kang WK; Park K; Choi HY; Lee HM; Baek SY; Lee H; Doh H; Kim BM; Kim CY; Jeon C; Jung CW
Clin Immunol; 2007 Dec; 125(3):257-67. PubMed ID: 17916447
[TBL] [Abstract][Full Text] [Related]
14. Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma.
Redman BG; Chang AE; Whitfield J; Esper P; Jiang G; Braun T; Roessler B; Mulé JJ
J Immunother; 2008; 31(6):591-8. PubMed ID: 18528294
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma.
Hersey P; Menzies SW; Halliday GM; Nguyen T; Farrelly ML; DeSilva C; Lett M
Cancer Immunol Immunother; 2004 Feb; 53(2):125-34. PubMed ID: 14600790
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.
Nestle FO; Alijagic S; Gilliet M; Sun Y; Grabbe S; Dummer R; Burg G; Schadendorf D
Nat Med; 1998 Mar; 4(3):328-32. PubMed ID: 9500607
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
Schott M; Feldkamp J; Lettmann M; Simon D; Scherbaum WA; Seissler J
Clin Endocrinol (Oxf); 2001 Aug; 55(2):271-7. PubMed ID: 11531937
[TBL] [Abstract][Full Text] [Related]
18. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
Gao J; Chen M; Peng ML; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
Chen Y; Huang A; Gao M; Yan Y; Zhang W
Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma.
Wang X; Bayer ME; Chen X; Fredrickson C; Cornforth AN; Liang G; Cannon J; He J; Fu Q; Liu J; Nistor GI; Cao W; Chen C; Dillman RO
J Surg Oncol; 2015 Jun; 111(7):862-7. PubMed ID: 25873455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
